Skip to main content

Table 1 Characteristics of the transgender women study population

From: A comparative study of transgender women accessing HIV testing via face-to-face and telemedicine services in Chiang Mai, Thailand during the COVID-19 pandemic and their risk of being HIV-positive

Characteristic

Total

(N = 637)

Telemedicine

(n = 260)

Face-to-Face

(n = 377)

P-value

n (%)

n (%)

n (%)

Age (years old)

   

0.415a

< 20

138 (21.7)

55 (21.2)

83 (22.0)

 

20–24

238 (37.4)

97 (37.3)

141 (37.4)

 

25–29

129 (20.2)

60 (23.1)

69 (18.3)

 

> 30

132 (20.7)

48 (18.4)

84 (22.3)

 

Median [Interquartile range]

23 [20–28]

23 [20–28]

23 [20–29]

 

Relationship status

   

0.047a*

Single

303 (73.9)

100 (68.0)

203 (77.2)

 

With a partner

107 (26.1)

47 (32.0)

60 (22.8)

 

NA

227

113

114

 

History of taking PrEP before HIV testing

   

0.256a

No

282 (70.5)

99 (66.9)

183 (72.6)

 

Yes

118 (29.5)

49 (33.1)

69 (27.4)

 

NA

237

112

125

 

History of taking PEP before HIV testing

   

0.403a

No

329 (83.3)

119 (80.9)

210 (84.7)

 

Yes

66 (16.7)

28 (19.1)

38 (15.3)

 

NA

242

113

129

 

History of drug abuse

   

0.147a

No

360 (90.9)

138 (93.9)

222 (89.2)

 

Yes

36 (9.1)

9 (6.1)

27 (10.8)

 

NA

241

113

128

 

Sex worker experience

   

0.776a

No

326 (83.8)

121 (82.9)

205 (84.4)

 

Yes

63 (16.2)

25 (17.1)

38 (15.6)

 

NA

248

114

134

 

HIV-tested during the window periods

   

0.831b

No

614 (96.4)

250 (96.1)

364 (96.6)

 

Yes

23 (3.6)

10 (3.9)

13 (3.5)

 

Channels for obtaining information about HIV testing or services from MPlus

   

0.644b

Recommended by friends

200 (44.9)

77 (44.5)

123 (45.1)

 

Staff at MPlus

142 (31.8)

59 (34.1)

83 (30.4)

 

Online channels

70 (15.7)

27 (15.6)

43 (15.7)

 

Self-seeking/other sources

34 (7.6)

10 (5.8)

24 (8.8)

 

NA

191

87

104

 
  1. Abbreviations: NA, not applicable; PrEP, pre-exposure prophylaxis; PEP, post-exposure prophylaxis
  2. a Fisher’s exact test; b Wilcoxon rank-sum test
  3. *P-value < 0.05